• Fri, May 5, 2023

Judah Frommer Reiterated (STOK) at Buy and Held Target at $28 on, May 5th, 2023

Judah Frommer of Credit Suisse, Reiterated "Stoke Therapeutics, Inc." (STOK) at Buy and Held Target at $28 on, May 5th, 2023.

Judah has made no other calls on STOK in the last 4 months.



There are 4 other peers that have a rating on STOK. Out of the 4 peers that are also analyzing STOK, 1 agrees with Judah's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Greg Harrison of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $12 on, Monday, May 1st, 2023


These are the ratings of the 3 analyists that currently disagree with Judah


  • Sumant Kulkarni of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $24 on, Wednesday, April 26th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $20 on, Tuesday, March 7th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023

Like: 👍